FDA Drugs recall ·

Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL)… recall

Recall number
D-0036-2026
Date
(initiated October 1, 2025)
Company / brand
Aspiro Pharma Limited
Survey No. 321, Biotech Park, Phase Iii, Siddipet (District), India
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd. by: ASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S. Contact Number: 1-866-495-1995, NDC 31722-307-25 (Carton), 31722-307-02 (Vial label).

Why was it recalled?

Presence of Particulate Matter: Particulate matter identified as glass

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot #: AS1240347A, Exp Date 09/2026; AS1240144A, Exp Date 05/2026; AS1240145A, AS1240146A, Exp Date 06/2026; AS1250295A, Exp Date 05/2027.

Distribution

Nationwide within the United States

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0036-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.